Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

IDEXX Laboratories, Inc. IDXX

Healthcare  —  Diagnostics & Research
519.26 5.87 1.14% as of 25 Sep
Market cap
$40.2B
P/E
36.2×
S&P 500 Member Cash Flow Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending)
Download Excel — free account

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Cash and Short Term Investments

+8 more quarters

 208.17 180.07 200.53 196.93
Receivables 566.88 552.38 603.54 627.08
Inventory 391.56 377.76 382.40 391.58
Other current assets 310.44 303.62 267.60 293.89
Total current assets 1,477.06 1,413.83 1,454.08 1,509.49
Property, Plant, Equpment (Net) 739.44 747.38 740.38 733.24
Goodwill and Intangible Assets (Total) 528.44 523.85 516.85 509.12
Long-term assets (Other) 513.57 542.48 552.79 567.73
Total non-current assets 1,909.66 1,936.93 1,931.42 1,932.85
Total Assets 3,386.71 3,350.76 3,385.50 3,442.34
Notes Payable 455.00 398.00 530.00 519.00
Accounts Payable 122.27 110.41 129.97 129.10
Accrued Expenses 488.86 530.15 453.55 453.17
Current Part of Debt 150.00 75.00 150.00 150.00
Current Revenue (Deferred) 35.69 35.26 36.33 36.40
Total current liabilities 1,251.81 1,148.81 1,299.85 1,287.67
Long Term Debt (Total) 374.83 374.84 299.85 299.87
Non-current Revenue (Deferred) 31.05 32.18 32.31 32.59
Long Term Tax Liability (Deferred) 3.72 31.87 44.60 52.64
Non-current Liabilities (Other) 57.62 56.53 54.03 56.50
Total non-current liabilities 573.72 596.56 529.54 542.10
Total liabilities 1,825.53 1,745.38 1,829.39 1,829.76
Additional Paid In Capital 1,792.79 1,826.75 1,861.08 1,910.29
Common Stock (Net) 10.83 10.84 10.85 10.87
Retained Earnings 6,143.71 6,391.90 6,670.35 7,008.76
Treasury Stock 6,319.42 6,561.36 6,927.40 7,259.75
Common Equity (Total) 1,561.19 1,605.38 1,556.10 1,612.58
Shareholders Equity (Total) 1,561.19 1,605.38 1,556.10 1,612.58
Shareholders Equity and Liabilities (Total) 3,386.71 3,350.76 3,385.50 3,442.34
Shares (Common) 80.00 79.71 79.24 78.87
Shareholders Equity (Tangible) 1,032.75 1,081.54 1,039.25 1,103.46
Net Debt 316.66 269.77 249.32 252.93
Total Debt 524.82 449.84 449.85 449.86

Fold the line items

In millions of $ except per-share values · columns are period end dates